Posted Apr. 13, 2012 at 9:19 a.m.
Research Triangle Park, N.C. — BioDelivery Sciences plans to file a new drug application for its opioid dependence treatment BEMA Buprenorphine in the first half of 2013....
Raleigh firm BDSI targets growing drug abuse, addiction markets
Post a comment
Print this blog postE-mail blog post
Share
Research Triangle Park, N.C. — BioDelivery Sciences plans to file a new drug application for its opioid dependence treatment BEMA Buprenorphine in the first half of 2013....
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 MedCity. All rights reserved.Please log in or register to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
The Skinny
Linux market still remains 'bread-and-butter' business at Red Hat
Duke's Vivek Wadhwa cracks Time 'Most Influential' list
IBM layoff update: North American cuts climb; mum is word down under
At last! Sprint 4G service formally launches in Triangle
Big Blue's layoff total climbs in RTP; North America total surges past 2,800
Big Blue layoff count nears 2,800 in North America alone
NC's high-tech job picture improves in May, but ...
IBM layoff count hits nearly 2,300 across 31 work groups
NC IDEA: Startup deal flow 'better than it has ever been'
IBM's job cuts are global, nearing 4,000; most are in U.S.













